Researchers Find Defects in Adult Stem Cell Niche May Cause Breast CancerOctober 05, 2005Washington, DC - Researchers at Georgetown's Lombardi Comprehensive Cancer Center have found that the onset of breast cancer may be due to defects in somatic adult stem cell niches that exist long before tumors develop. The research, published in the October 2005 issue of Tissue and Cell, is the first to examine the highly specialized microenvironment, termed the stem cell niche, which surrounds adult stem cells, and its role in breast cancer development. These niches are key regulators of stem cell activity in mammary tissue, and defects that develop in these groups of cells can give rise to breast cancer. "This study helps us understand adult stem cells differently than we previously did. Particularly, when looking for the causes of breast cancer, we must take into account the stem cell as well as the environment that surrounds it," said Robert Dickson, Ph.D., co-author of the paper and co-director of the breast cancer program at the Lombardi Comprehensive Cancer Center. The study used genetically engineered mice as models of ductal or lobular breast cancer that is caused by overproduction of certain proteins. These proteins (c-Myc and TGF-alpha) exist naturally in the body, but when produced in excess in mammary tissue cells, breast cancer can develop. Gloria Chepko, Ph.D., a postdoctoral fellow and the paper's lead author, built on previous research results that demonstrated the existence of five different types of cells in normal breast tissue. Two of the cell types are stem cell-like and give rise to the other three. For the present study, she devised a method to identify all the cell types at low magnification, allowing more cells to be counted. This method revealed not only that each cell population has a different size in normal breast tissue, but also that the different cells are arranged in particular relationships to each other. The arrangements form repeating units called stem cell niches and provide nest-like microenvironments that house the adult stem cells and their immediate daughter cells. In the mice that expressed excess amounts of either of the cancer-producing proteins, the size of the cell populations were significantly changed relative to each other. The order of the cell arrangements was disrupted in the stem cell niches of mice with breast cancer. These results provided the first evidence that each cell population may play a different role in the development of breast cancer and that the environment in which a cell grows can influence its chance of becoming cancerous. "The results also show how complicated cancer is as a disease. Although it's not something that will be solved easily or quickly, our study reveals important information on the genesis of breast cancer in the body," said Chepko. The study was funded in part by a grant from the National Institutes of Health and by a grant from the Department of Defense, both of which received funds from sales of the U.S. Postal Service breast cancer stamp. Co-authors include Rebecca Slack, M.S., Deborah Carbott, Sonya Khan and Lynley Steadman from Georgetown University. Georgetown University Medical Center |
|||||||||||||||||||||
| Related Breast Cancer Current Events and Breast Cancer News Articles Menopause-cardiology consensus statement on cardiovascular disease and on HRT A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT. Researchers Identify Role of Gene in Tumor Development, Growth and Progression Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. UCLA researchers create 'fly paper' to capture circulating cancer cells Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. Fertility procedures need not delay breast cancer treatment for younger women A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion. Coffee break: Compound brewing new research in colon, breast cancer A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. Drugs to treat anemia in cancer patients linked to thromboembolism Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center. Discovery in worms by Queen's researchers points to more targeted cancer treatment Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment. FDA approved leukemia drugs shows promise in ovarian cancer cells The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found. Carnegie Mellon researchers link health-care debate to risk of dying in US and Europe The current health care debate in the United States is complicated. Trade-offs between heath care expenditures, lifestyle choices and life expectancy have been suggested but seldom clearly demonstrated. Scientists uncover new key to the puzzle of hormone therapy and breast cancer The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||